GILD

Rheumatoid Arthritis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 75+ Leading Players Wheeling the Therapeutics Landscape

04/28 01:00 pm

Mag 7 Earnings Bonanza, Fed Await Stocks at Record Highs: What to Expect

04/27 05:36 am

Kailera Therapeutics' Strong IPO Validates "NewCo" Strategy

04/23 12:08 pm

Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026

04/23 07:00 am

Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026

04/22 07:00 am

Non-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight

04/16 01:00 pm

Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update

04/08 06:00 am

Gilead Acquisition Spree Continues With $3 Billion Tubulis Deal

04/07 12:06 pm

Trump Imposes 100% Drug Tariffs: 5 Pharma Stocks That Won’t Pay a Dime

04/06 01:20 pm

A Healthy Return: Drug Spin-off Nets Keymed Up To $320M

04/02 04:16 am

2 Defensive Dividend Payers Growing Fast on AI Demand

03/31 07:43 am

Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases

03/31 01:30 am

Bile Duct Cancer Market to Grow by $1.07 Billion During 2026-2030: Key Trends, Investment Opportunities and Competitive Strategies Analyzed

03/30 06:00 am

SK pharmteco to Host Innovations in Pharmaceutical Manufacturing Symposium in Cambridge, Massachusetts

03/26 10:00 am

Gilead Powers Up Its Inflammation Pipeline With Over $1.5 Billion Acquisition

03/24 01:58 pm

Galapagos en Gilead in vergevorderde gesprekken over samenwerking om een first-in-class T-cel-engagerprogramma voor auto-immuunziekten verder te ontwikkelen

03/23 06:25 pm

Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases

03/23 06:25 pm

This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal

03/16 07:13 pm

These 3 Cash Flow Machines Provide Stability in Uncertain Markets

03/06 11:09 am

Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing

03/04 07:15 pm

PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race

02/26 02:35 pm

Advanced Drug Delivery Market to Grow 10.2% Annually Through 2030

02/25 01:54 pm

Gilead Snaps Up Arcellx For $115 Per Share — A $7.8 Billion Bet On Cancer Therapy

02/25 11:09 am

Arcellx Surges as Gilead’s $7.8B Offer Locks In a 68% Premium

02/23 11:48 am

Gilead Buys Arcellx To Fast-Track Next-Gen Myeloma Drug

02/23 08:51 am

Xilio Therapeutics Announces Pricing of Underwritten Offering

02/11 10:34 pm

Software Slump Resumes, Bitcoin Plunges To $66,000: What's Moving Markets Wednesday?

02/11 03:23 pm

Hepatitis B Treatment Market Size is Projected to Reach USD 7.74 Billion by 2033 Due to the Increasing Disease Management Trends Globally

02/11 05:00 am

Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica

02/03 02:56 am

This Top Non-Tech AI Trade for 2026 Pays a Huge 11.6% Dividend

02/02 07:33 am

Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle

01/28 06:51 am

Autologous Cell Therapy Market Size to Reach US$ 44.55 Billion by 2033 | Astute Analytica

01/27 02:43 pm

4D Path Joins Phase II Clinical Trial to Advance Predictive Biomarkers in Bladder Cancer

01/22 01:00 pm

Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs

01/13 08:00 am

GSK/Ionis Partnered Investigational Drug Shows Strong Results In Large Hepatitis B Studies

01/07 12:48 pm

3 Cash-Flow Machines Investors May Want Heading Into 2026

01/02 05:11 pm

Repare Therapeutics Stock Rises As Gilead Secures Cancer Asset For $30 Million

12/24 09:36 am

3 Companies Turning Big Cash Flow Into Bigger Shareholder Gains

12/15 02:41 pm

Gilead's Experimental Combo Tablet For HIV Treatment Hits Primary Goal

12/15 01:15 pm

Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition

12/06 10:30 am

CAR T-Cell Therapy Market Industry Trends and Global Forecasts to 2035 by Target Antigens, Target Indication, Key Geographies, Sales Forecast of Drugs and Leading Players

12/05 06:41 am

Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away

12/03 10:34 am

Nurix Therapeutics Announces Webcast to Review New and Updated Data from the Phase 1 Clinical Trial of BTK Degrader Bexobrutideg (NX-5948) To Be Presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition

12/01 08:00 am

U.S. CAR T-Cell Therapies Market Grows at 30.4% CAGR, Soars USD 42.61 Billion by 2035

11/27 12:00 pm

Antitumor ADC Drugs Market Forecast Shows Strong 12.86% CAGR Through 2035

11/27 10:00 am

Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial

11/13 02:55 pm

Gilead's Trodelvy Misses Main Goal In Breast Cancer Study But Shows Early Survival Trend

11/07 11:10 am

Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

11/03 10:00 am

Gilead's HIV Drugs Power Earnings Beat, Company Eyes Multiple Launches By 2026

10/31 01:41 pm

Kuick Research Releases Landmark Study On US Orphan Drug Rare Disease Market Highlighting Investment And Innovation Opportunities Through 2030

10/31 06:19 am